Form 4: STERIS plc Executive Acquires Shares and Stock Options
SEC Form 4
Renato Tamaro, V.P. & Corporate Treasurer of STERIS plc, reports acquisition of ordinary shares and stock options.
Summary
- On June 4, 2024, Renato Tamaro, V.P. & Corporate Treasurer of STERIS plc, acquired 663 ordinary shares at $0.
- Following the transaction, Tamaro directly owns 6,879 ordinary shares, including 1,915 restricted shares that will vest over the next few years.
- Tamaro also acquired 2,264 employee stock options with an exercise price of $251.34, exercisable in installments starting June 4, 2025, and expiring on June 4, 2034.
- Following the transaction, Tamaro directly owns 2,264 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a sign of confidence, but without additional context, it's difficult to gauge the overall impact.
Positives
- The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units (RSUs).
- The vesting schedules for the restricted shares and stock options are typical for executive compensation plans, designed to incentivize long-term performance and retention.
- Comparing the size of the stock option grant and RSU grants to those of executives at comparable companies like Medtronic, Boston Scientific, or Abbott Laboratories would provide a better understanding of the relative generosity of STERIS's compensation practices.
Stakeholder Impact
- The acquisition of shares and stock options by a company executive can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of transaction: Acquisition of ordinary shares and stock options. |
| 06/06/2024 | Date of signature of the report. |
| 10/01/2024 | 258 restricted ordinary shares lapse. |
| 06/02/2025 | 241 restricted ordinary shares lapse. |
| 06/02/2025 | 144 restricted ordinary shares lapse. |
| 06/02/2025 | 141 restricted ordinary shares lapse. |
| 06/04/2025 | 221 restricted ordinary shares lapse. |
| 10/01/2025 | 86 restricted ordinary shares lapse. |
| 06/04/2025 | 566 employee stock options become exercisable. |
| 06/01/2026 | 241 restricted ordinary shares lapse. |
| 06/02/2026 | 141 restricted ordinary shares lapse. |
| 06/04/2026 | 221 restricted ordinary shares lapse. |
| 06/04/2026 | 566 employee stock options become exercisable. |
| 06/04/2027 | 221 restricted ordinary shares lapse. |
| 06/04/2027 | 566 employee stock options become exercisable. |
| 06/05/2028 | 566 employee stock options become exercisable. |
| 06/04/2034 | Expiration date of employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.